Hehlmann R, Lauseker M, Saussele S. et al. Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase. ASH 59th Annual Meeting & Exhibition, abstract 897.
DHC 2022: ‘Optimale fludarabine-waarde kan doel worden bij CAR-T-celtherapie’
mrt 2022 | Leukemie